Alnylam Pharmaceuticals reported $237.96M in Trade Debtors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US USD 63.08M 6.94M
Agios Pharmaceuticals AGIO:US USD 2.21M 3.39M
Alnylam Pharmaceuticals ALNY:US USD 237.96M 53.45M
Amgen AMGN:US USD 5.56B 237M
Arrowhead Research ARWR:US USD 39.57M 38.16M
Biocryst Pharmaceuticals BCRX:US USD 50.6M 7.99M
Biomarin Pharmaceutical BMRN:US USD 461.32M 41.69M
Intercept Pharmaceuticals ICPT:US USD 26.86M 694K
Mirati Therapeutics MRTX:US USD 3.74M 2.05M
Moderna Inc MRNA:US USD 1.63B 1.19B
Neurocrine Biosciences NBIX:US USD 350M 48.8M
Novartis NVS:US USD 8.33B 346M
Ptc Therapeutics PTCT:US USD 155.61M 31.16M
Regeneron Pharmaceuticals REGN:US USD 5.33B 219.6M
Sangamo Biosciences SGMO:US USD 4.47M 574K
Sarepta Therapeutics SRPT:US USD 259.7M 36.25M
Takeda 4502:JP JPY 779.87B 20.66B
Ultragenyx Pharmaceutical RARE:US USD 40.44M 9.28M
Vertex Pharmaceuticals VRTX:US USD 1.44B 57M
Xencor XNCR:US USD 29M 15.88M
YTE INCY:US USD 644.88M 26.69M